A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol

OBJECTIVE: The aim of the Patient/Physician Reported Efficacy Determination In Clinical Practice Trial (PREDICT; ClinicalTrials identifier NCT01255761) was to compare the patient‐reported Routine Assessment of Patient Index Data 3 (RAPID‐3) instrument with the investigator‐based Clinical Disease Act...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtis, Jeffrey R., Churchill, Melvin, Kivitz, Alan, Samad, Ahmed, Gauer, Laura, Gervitz, Leon, Koetse, Willem, Melin, Jeffrey, Yazici, Yusuf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063165/
https://www.ncbi.nlm.nih.gov/pubmed/26316013
http://dx.doi.org/10.1002/art.39322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063165/
https://www.ncbi.nlm.nih.gov/pubmed/26316013
http://dx.doi.org/10.1002/art.39322

Ejemplares similares